HPV (human papillomavirus) and hepatitis B (HBV) are two entirely different viruses that infect different parts of the body, belong to different viral families, and cause different diseases. They do share a few notable traits: both are DNA viruses, both can be transmitted sexually, and both can lead to cancer over time. That overlap is likely why confusion between them persists, but the similarities are surface-level. Understanding how they actually differ matters for your health decisions, from which vaccines you need to which screening tests apply to you.
Two Different Viruses Targeting Different Organs
HPV is a small, non-enveloped DNA virus that belongs to the Papillomaviridae family. It infects epithelial cells, which are the skin and mucosal cells lining surfaces like the cervix, throat, anus, and genitals. There are more than 200 known types of HPV, and they range from types that cause common warts on your hands to high-risk types that can trigger cancer. The virus has a strong preference for these surface tissues and does not spread to internal organs like the liver.
Hepatitis B, by contrast, is a member of the Hepadnaviridae family. It targets hepatocytes, the main functional cells of the liver. HBV is an enveloped virus, meaning it has an outer lipid layer that HPV lacks. Once inside the liver, HBV replicates within those cells and can persist there for decades, interacting with numerous cellular proteins and gradually damaging liver tissue.1PubMed Central. Hepatitis B Virus-Associated Hepatocellular Carcinoma The two viruses have essentially nothing in common at the cellular level beyond both carrying DNA as their genetic material.
How Each Virus Spreads
Both HPV and HBV can be transmitted through sexual contact, which is one reason people sometimes lump them together. But the details of transmission are quite different.
HPV spreads primarily through skin-to-skin contact, especially during vaginal, anal, or oral sex. It does not require an exchange of bodily fluids. Condoms reduce the risk but don’t eliminate it completely, because the virus can live on skin that a condom doesn’t cover. HPV is extraordinarily common: most sexually active people will encounter at least one type of the virus at some point in their lives.
HBV spreads through infected blood and other body fluids, including semen and vaginal secretions. Sexual contact is one route, but HBV also transmits through shared needles, needlestick injuries, and from mother to child during birth. A key difference is the blood-borne route: healthcare workers are at occupational risk for HBV through accidental exposure to infected blood, a scenario that doesn’t apply to HPV. In women who carry both HBV surface antigen and e antigen, vertical transmission to the newborn during delivery reaches roughly 90%.2PubMed Central. Pregnancy and sexually transmitted viral infections
HPV can also pass from mother to infant during vaginal delivery, though the consequences differ. One study found that about 40% of newborns delivered vaginally to HPV 16/18-positive mothers tested positive for the virus at birth, compared with about 27% delivered by cesarean section.3PubMed. Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery In rare cases, neonatal HPV infection with types 6 or 11 can lead to a condition called juvenile-onset recurrent respiratory papillomatosis, where wart-like growths develop in a child’s airway.2PubMed Central. Pregnancy and sexually transmitted viral infections That is a far cry from the chronic liver infection a baby can acquire from HBV.
The Cancer Connection
Here is where the two viruses draw the most comparison, and where researchers have studied them side by side. Both HPV and HBV are established causes of cancer, a fact that places them in a small club of infectious agents directly linked to malignancy. Both are DNA viruses that integrate into the host genome in invasive tumors, a shared molecular behavior that contributes to how they eventually drive cells toward cancer.4Nature. Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers But the cancers they cause, and the mechanisms behind them, are distinct.
HPV is considered a necessary cause of cervical cancer, meaning virtually all cervical cancers involve HPV infection. Beyond the cervix, HPV is linked to a substantial share of cancers at other sites: roughly 90–93% of anal cancers, 12–63% of oropharyngeal cancers, 36–40% of penile cancers, 40–64% of vaginal cancers, and 40–51% of vulvar cancers.5PubMed. Beyond cervical cancer: burden of other HPV-related cancers among men and women The virus drives cancer through specific viral proteins, particularly E6 and E7, which are produced continuously in infected cells and disrupt normal cell-growth controls.6PubMed Central. Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy These proteins also trigger a state of chronic oxidative stress that damages DNA and destabilizes the genome, pushing cells further down the path toward malignancy.7PubMed Central. HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells
Hepatitis B takes a different path to cancer. Chronic HBV infection affects more than 250 million people worldwide and can progressively lead to liver cirrhosis, a condition of severe scarring that is itself an independent risk factor for hepatocellular carcinoma, the most common form of liver cancer.1PubMed Central. Hepatitis B Virus-Associated Hepatocellular Carcinoma But HBV can also promote liver cancer directly, even without cirrhosis, through several mechanisms that alter liver cell behavior over time.8PubMed Central. The Mechanisms of HBV-Induced Hepatocellular Carcinoma So while HPV’s cancer story centers on epithelial surfaces across the body, HBV’s cancer story is almost entirely about the liver.
Vaccination Is Available for Both, but the Vaccines Are Completely Different
One of the most significant similarities between HPV and HBV is that both are preventable through vaccination. In fact, these are the only two cancer-causing viruses for which effective preventive vaccines currently exist. But the vaccines themselves work differently and are given on different schedules to different populations.
The hepatitis B vaccine uses a recombinant form of the virus’s surface antigen (HBsAg), produced in yeast. After the standard three-dose schedule, it achieves seroprotection rates of 93–100% in adults and children.9PubMed. Recombinant hepatitis B vaccine: a review of its immunogenicity and protective efficacy against hepatitis B In most countries, this vaccine is given at birth or in early infancy and has been a routine part of childhood immunization for decades. Healthcare workers who may encounter infected blood also receive it.
HPV vaccines use virus-like particles (VLPs) made from the major capsid protein L1. These particles look almost identical to real HPV under a microscope but contain no viral DNA, so they can’t cause infection. They generate antibody levels that persist at about ten times the level seen after natural infection for at least four years, and the protection they offer has held up strongly in both clinical trials and national immunization programs.10PubMed. Chapter 12: Prophylactic HPV vaccines: underlying mechanisms 11PubMed Central. Explanations for the high potency of HPV prophylactic vaccines The HPV vaccine is typically recommended for preteens around age 11–12 but can be given as early as 9. Adults up to age 26 are routinely recommended for vaccination, with some catch-up guidance extending to age 45.
A practical point: getting vaccinated against one virus does nothing for the other. The HBV vaccine protects only against hepatitis B, and the HPV vaccine protects only against the HPV types it covers. If you need both, you need both.
How Doctors Test for Each Virus
Screening and diagnosis also look nothing alike for HPV and HBV, reflecting their different organs and disease processes.
HPV testing usually happens during cervical cancer screening. The main approach is DNA testing on a cervical sample, which detects the presence of high-risk HPV types. This test is often paired with a Pap smear (cervical cytology), and the combination catches more precancerous changes than either test alone. One study found that HPV DNA testing had a sensitivity of about 84% for detecting higher-grade precancerous lesions, compared with about 64% for cytology alone.12PubMed Central. Assessment of Cervicovaginal Smear and HPV DNA Co-Test for Cervical Cancer Screening: Implications for Diagnosis and Follow-Up Strategies There is no routine blood test for HPV. You can’t walk into a clinic and get your “HPV levels” checked the way you might for other infections. Most HPV infections are diagnosed either through screening programs or when symptoms like warts or abnormal cells appear.
Hepatitis B diagnosis is entirely blood-based. Doctors use a panel of serological markers to determine your hepatitis B status: surface antigen (HBsAg), surface antibody (anti-HBs), and core antibody (anti-HBc). Together, these three tests reveal whether you’re susceptible to the virus, immune from vaccination, immune from a resolved past infection, or chronically infected.13Australian Family Physician. Hepatitis B serology Additional tests like HBV DNA viral load can assess how actively the virus is replicating. This kind of detailed blood-based profiling doesn’t exist for HPV.
Treatment Approaches Have Little in Common
Treatments for the two viruses diverge sharply, largely because the diseases they cause are so different.
For chronic hepatitis B, the main goal is suppressing viral replication to slow or prevent liver damage. Modern antiviral drugs like tenofovir and entecavir have become the standard treatment. These drugs don’t cure HBV in most cases, but they effectively suppress the virus and reduce the progression to cirrhosis and liver cancer.14PubMed. Anti-viral treatment and cancer control Patients with chronic HBV often take these medications for years or even lifelong.
HPV has no approved systemic antiviral treatment. Your immune system clears most HPV infections on its own within a year or two. When HPV does cause disease, treatment targets the consequences rather than the virus itself: precancerous cervical changes are removed by procedures like excision or ablation, genital warts are treated with topical medications or physically removed, and HPV-related cancers are treated with surgery, radiation, or chemotherapy, depending on the site and stage. Some research has explored therapeutic HPV vaccines and RNA-based therapies that could target HPV-associated cancers directly, with early encouraging results.14PubMed. Anti-viral treatment and cancer control But as of now, there’s no pill you can take to clear an existing HPV infection.
Why People Confuse Them
The confusion between HPV and hepatitis B is widespread and well documented. Researchers studying teenagers’ understanding of vaccines found limited knowledge of both diseases. Boys commonly believed that HPV affects only girls, and both genders showed confusion about the relationship between HPV and cancer.15PubMed Central. Teenagers’ understandings of and attitudes towards vaccines and vaccine-preventable diseases: a qualitative study Broader research has documented stark knowledge gaps about HPV among policymakers, healthcare providers, parents, and teens in both developed and developing countries.16PubMed. Chapter 25: Education, training, and communication for HPV vaccines
Several factors feed the mix-up. Both viruses are sexually transmitted, both are preventable by vaccination, and both are linked to cancer. The acronyms sound somewhat similar, especially when spoken aloud quickly. And because both vaccines are often discussed in the same public health campaigns aimed at adolescents, it’s easy to blur the two into a single vague category of “infections you get vaccinated against as a teenager.” The reality is that they are as different from each other as a skin infection and a liver infection, which is exactly what they are.
What Happens When Someone Has Both
It is possible to be infected with HPV and HBV at the same time, and emerging research suggests this combination may be worse than either infection alone, at least for cervical disease. A recent study found that co-infection with HPV and HBV significantly increases the risk of all levels of cervical lesions compared with HPV or HBV alone. The odds ratios were striking: about 3.1 for low-grade lesions, 3.5 for high-grade lesions, and roughly 11.5 for cervical cancer itself.17PubMed. The Impact of HPV/HBV Coinfection on Cervical Cancer Risk: Potential Mediating Role of Ki67 The interaction between the two viruses appeared to be synergistic, meaning the combined effect was greater than the sum of each virus acting independently.
This doesn’t mean HBV directly causes cervical cancer. Rather, chronic HBV infection may alter immune function or cellular proliferation in ways that make the cervix more vulnerable to HPV-driven changes. Research from Burkina Faso looking at women treated for chronic hepatitis found that while chronic hepatitis B or C infection didn’t seem to increase the odds of acquiring HPV in the first place, co-infection with HBV, HCV, or HIV was a risk factor for carrying HPV.18American Journal of Molecular Biology. HPV/HBV or HPV/HCV Co-Infections in Women Treated for Chronic Hepatitis at Hôpital Saint Camille in Ouagadougou, Burkina Faso The picture is still being assembled, but the take-home is straightforward: having one of these viruses is reason enough to stay vigilant about the other.
Other Sexually Transmitted Viruses Linked to Cancer
HPV and HBV are not the only sexually transmissible viruses that cause cancer. They’re just the two for which vaccines exist. Hepatitis C, which is sometimes confused with hepatitis B, also causes liver cancer but spreads mainly through blood-to-blood contact and has no vaccine yet. Human herpesvirus type 8 is linked to Kaposi sarcoma. Human T-cell lymphotropic virus type 1 can lead to a form of leukemia. And Epstein-Barr virus, which causes mono, is associated with several lymphomas and nasopharyngeal cancer.19Elsevier / Social Science & Medicine. The pharmaceuticalization of sexual risk: Vaccine development and the new politics of cancer prevention All of these viruses are transmitted person-to-person, and all have established causal links to specific cancers.
The existence of this broader group underscores why HPV and HBV sometimes get conflated. When people hear “sexually transmitted virus that causes cancer,” they may not register which virus is being discussed. The specificity matters, though. Each of these viruses targets different cells, causes different diseases, and requires a different approach to prevention, screening, and treatment. Lumping them together as “STI cancers” obscures the very different steps you’d take to protect yourself against each one. Getting the hepatitis B vaccine protects your liver. Getting the HPV vaccine protects your cervix, throat, and other mucosal surfaces. Understanding that distinction is the single most useful thing you can take from the comparison.